INTEGRILIN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, UK.

Active ingredients

The drug INTEGRILIN contains one active pharmaceutical ingredient (API):

1	Eptifibatide UNII NA8320J834 - EPTIFIBATIDE
	Eptifibatide is an inhibitor of platelet aggregation and belongs to the class of RGD (arginine-glycine-aspartate)-mimetics. Eptifibatide reversibly inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor and other adhesive ligands to the glycoprotein (GP) IIb/IIIa receptors.
	Read more about Eptifibatide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INTEGRILIN Solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC16	Eptifibatide	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8683B, 8684C
CA	Health Products and Food Branch	02240351, 02240352
EE	Ravimiamet	1183845, 1183856
ES	Centro de información online de medicamentos de la AEMPS	99109001, 99109002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	136093, 136101
FR	Base de données publique des médicaments	60124020, 66506404
GB	Medicines & Healthcare Products Regulatory Agency	48489, 48500
HK	Department of Health Drug Office	46243, 46244
IL	מִשְׂרַד הַבְּרִיאוּת	3734, 3735
IT	Agenzia del Farmaco	034489017, 034489029
LT	Valstybinė vaistų kontrolės tarnyba	1028451, 1028452, 1050913
NL	Z-Index G-Standaard	14298406, 14298414
NL	Z-Index G-Standaard, PRK	53708, 53716
NZ	Medicines and Medical Devices Safety Authority	7864, 7865
PL	Rejestru Produktów Leczniczych	100100483, 100100490
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65094001, W65095001
SG	Health Sciences Authority	11222P, 11223P
US	FDA, National Drug Code	0085-1136, 0085-1177
ZA	Health Products Regulatory Authority	31/8.2/0540